BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17526459)

  • 1. Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: correlation with disease stage and prognosis.
    Kara IO; Sahin B; Gunesacar R
    Adv Ther; 2007; 24(1):29-40. PubMed ID: 17526459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily.
    Molica S; Vitelli G; Levato D; Crispino G; Dell'Olio M; Dattilo A; Matera R; Gandolfo GM; Musto P
    Haematologica; 1998 May; 83(5):398-402. PubMed ID: 9658722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
    Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M
    Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome.
    Fayad L; Keating MJ; Reuben JM; O'Brien S; Lee BN; Lerner S; Kurzrock R
    Blood; 2001 Jan; 97(1):256-63. PubMed ID: 11133769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Serum Soluble CD27 Level Correlates with Poor Performance Status and Reduced Survival in Patients with Advanced Lung Cancer.
    Kashima J; Okuma Y; Hosomi Y; Hishima T
    Oncology; 2019; 97(6):365-372. PubMed ID: 31533124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status.
    Lech-Maranda E; Grzybowska-Izydorczyk O; Wyka K; Mlynarski W; Borowiec M; Antosik K; Cebula-Obrzut B; Makuch-Lasica H; Nowak G; Klimkiewicz-Wojciechowska G; Wawrzyniak E; Bilinski P; Robak T; Warzocha K
    Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):477-86. PubMed ID: 22945689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia.
    Wierda WG; Johnson MM; Do KA; Manshouri T; Dey A; O'Brien S; Giles FJ; Kantarjian H; Thomas D; Faderl S; Lerner S; Keating M; Albitar M
    Br J Haematol; 2003 Feb; 120(3):452-6. PubMed ID: 12580959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus.
    Font J; Pallares L; Martorell J; Martinez E; Gaya A; Vives J; Ingelmo M
    Clin Immunol Immunopathol; 1996 Dec; 81(3):239-43. PubMed ID: 8938100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia.
    Kamper EF; Papaphilis AD; Angelopoulou MK; Kopeikina LT; Siakantaris MP; Pangalis GA; Stavridis JC
    Clin Biochem; 1999 Nov; 32(8):639-45. PubMed ID: 10638947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells.
    Kato K; Chu P; Takahashi S; Hamada H; Kipps TJ
    Exp Hematol; 2007 Mar; 35(3):434-42. PubMed ID: 17309824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
    Molica S; Vitelli G; Levato D; Levato L; Dattilo A; Gandolfo GM
    Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome.
    van der Vuurst de Vries RM; Mescheriakova JY; Runia TF; Jafari N; Siepman TA; Hintzen RQ
    JAMA Neurol; 2017 Mar; 74(3):286-292. PubMed ID: 28055081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies.
    Kara IO; Sahin B; Gunesacar R
    Adv Ther; 2007; 24(4):741-7. PubMed ID: 17901023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma.
    Kok M; Bonfrer JM; Korse CM; de Jong D; Kersten MJ
    Tumour Biol; 2003; 24(1):53-60. PubMed ID: 12743427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells naturally induced during dengue virus infection release soluble CD27, the plasma level of which is associated with severe forms of pediatric dengue.
    Castañeda DM; Salgado DM; Narváez CF
    Virology; 2016 Oct; 497():136-145. PubMed ID: 27467579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients.
    Murase S; Saio M; Andoh H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
    Neurol Res; 2000 Jul; 22(5):434-42. PubMed ID: 10935213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated IL-17A and IL-22 regulate expression of inducible CD38 and Zap-70 in chronic lymphocytic leukemia.
    Kouzegaran S; Siroosbakht S; Farsad BF; Rezakhaniha B; Dormanesh B; Behnod V; Tanha AS
    Cytometry B Clin Cytom; 2018 Jan; 94(1):143-147. PubMed ID: 27718514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and release of CD27 in human B-cell malignancies.
    van Oers MH; Pals ST; Evers LM; van der Schoot CE; Koopman G; Bonfrer JM; Hintzen RQ; von dem Borne AE; van Lier RA
    Blood; 1993 Dec; 82(11):3430-6. PubMed ID: 8241510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.